{
    "nct_id": "NCT04170348",
    "official_title": "Daily Vitamin D for Sickle-cell Respiratory Complications",
    "inclusion_criteria": "1. Diagnosis of sickle cell disease (Hb SS, Hb SC, Hb S-Beta-thalassemia)\n2. Age 3-20 years old\nHealthy volunteers allowed\nMust have minimum age of 3 Years\nMust have maximum age of 20 Years",
    "exclusion_criteria": "1. Patient unwilling or unable to provide written informed consent (and assent, if applicable)\n2. Patient unable or unwilling to comply with requirements of the clinical trial\n3. Participation in another clinical trial\n4. Current diagnosis of rickets\n5. History of hypercalcemia or diagnosis of any medical condition associated with hypercalcemia, including primary hyperparathyroidism, malignancy, sarcoidosis, tuberculosis, granulomatous disease, familial hypocalciuric hypercalcemia\n6. Current use of corticosteroids, excluding inhaled steroids\n7. Current use of anticonvulsants (phenytoin, phenobarbital, carbamazepine)\n8. Therapy with thiazide diuretics or lithium carbonate\n9. Known liver or renal disease\n10. Patients taking medications for pulmonary complications of sickle cell disease not on a stable dose of medications, as defined by a change in medications or doses within the three months prior to study entry\n11. Patients on chronic red blood cell transfusion therapy",
    "miscellaneous_criteria": ""
}